BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28957553)

  • 1. Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.
    Walker UA; Mueller RB; Jaeger VK; Theiler R; Forster A; Dufner P; Ganz F; Kyburz D
    Rheumatology (Oxford); 2017 Oct; 56(10):1707-1712. PubMed ID: 28957553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
    Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
    Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T; Swearingen CJ; Bergman M; Yazici Y
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients.
    Bossert M; Prati C; Vidal C; Bongain S; Toussirot E; Wendling D
    Joint Bone Spine; 2012 Jan; 79(1):57-62. PubMed ID: 21550283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
    Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
    Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
    Kim SK; Park SH; Bae J; Son JT; Choe JY
    Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
    Pincus T; Swearingen CJ; Bergman MJ; Colglazier CL; Kaell AT; Kunath AM; Siegel EL; Yazici Y
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
    Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
    Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assessment of Rheumatoid Arthritis Disease Activity Using a Smartphone Application. Development and 3-month Feasibility Study.
    Nishiguchi S; Ito H; Yamada M; Yoshitomi H; Furu M; Ito T; Shinohara A; Ura T; Okamoto K; Aoyama T; Tsuboyama T
    Methods Inf Med; 2016; 55(1):65-9. PubMed ID: 26391694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI.
    Yokogawa N; Kaneko T; Nagai Y; Nunokawa T; Sawaki T; Shiroto K; Shimada K; Sugii S
    Mod Rheumatol; 2015 Mar; 25(2):264-9. PubMed ID: 25156777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis.
    Muñoz JGB; Giraldo RB; Santos AM; Bello-Gualteros JM; Rueda JC; Saldarriaga EL; Angarita JI; Arias-Correal S; Vasquez AY; Londono J
    Clin Rheumatol; 2017 May; 36(5):1143-1148. PubMed ID: 28013433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.
    Heegaard C; Dreyer L; Egsmose C; Madsen OR
    Clin Rheumatol; 2013 Oct; 32(10):1493-500. PubMed ID: 23754243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of indices of activity evaluation in rheumatoid arthritis.
    Hamdi W; Néji O; Ghannouchi MM; Kaffel D; Kchir MM
    Ann Phys Rehabil Med; 2011 Oct; 54(7):421-8. PubMed ID: 21996547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis.
    Uhlig T; Kvien TK; Pincus T
    Ann Rheum Dis; 2009 Jun; 68(6):972-5. PubMed ID: 18957489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T
    Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T; Yazici Y; Bergman MJ
    Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
    Pincus T; Furer V; Keystone E; Yazici Y; Bergman MJ; Luijtens K
    Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1142-9. PubMed ID: 21485024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.